Aller au contenu
Aller au pied de page

News
Careers
Contact us
FR EN

MYNOCINE®

MYNOCINE®

Internal Medicine

MYNOCINE®

Minocycline

MYNOCINE 100mg, capsule

Description

Product information and Transparency Commission notices (French)

Retour en haut de page

Follow us
LinkedIN
Instagram

Join us
Careers

Contact us
Contact us

If you wish to report a pharmacovigilance case, a quality defect or request medical information, please contact +33 (0)1 41 12 18 83 or pvlaboratoirexo@universalmedica.com

You can also report adverse reactions directly via the national reporting system: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) and the network of Regional Pharmacovigilance Centers – website: https://signalement.social-sante.gouv.fr/

Laboratoire X.O undertakes to comply with the Promotional Information Charter and Certification Standards in force. The person you have met who provides information by canvassing or canvassing is able to introduce him or herself to you and answer any questions you may have concerning the rules of professional ethics to which he or she must adhere with regard to healthcare professionals. In addition, you have the opportunity to express your views on the information provided to you, in particular its scientific and medico-economic quality, its objectivity and its compliance with current laws and regulations, as well as with the Charter, at the following e-mail address: info@laboratoirexo.fr. Laboratoire X.O has a quality policy for promotional information, available on request from info@laboratoirexo.fr.

Copyright 2024 - SI_LAXO_04-112023
General terms of use
Pharmaceutical promotional information policy (French)